Experimental autoimmune encephalomyelitis (EAE)-prone C57BL/6 mice are used as a model of human multiple sclerosis. We immunize mice with myelin oligodendrocyte glycoprotein (MOG), DNA-histone and DNA-methylated bovine serum albumin (met-BSA) complexes to reveal different characteristics of EAE development including bone marrow lymphocyte proliferation and differentiation profiles of hematopoietic stem 
| INTRODUCTION
Multiple sclerosis (MS) is the inflammatory and demyelinating disease of the central nervous system (CNS) with perivascular infiltrates composed largely of macrophages and T lymphocytes. Numerous studies support the role of autoimmune mechanisms in the destruction of myelin, while the precise cause of MS remains unknown. 1 Data indicate that activated myelin-reactive CD4 + T cells may be principal mediators of MS. 1 Several recent findings also specify an important role of B cells and autoantibodies (auto-Abs) against myelin autoantigens in MS pathogenesis. [1] [2] [3] The appearance of oligoclonal immunoglobulin G (IgG) and increased levels of antibodies (Abs) in the cerebrospinal fluid (CSF), the accumulation of clonal B cells in the CSF, and lesions of MS patients provide key evidence for the involvement of a humoural response in demyelination. 4 Evidence from recent clinical studies in humans and animal models demonstrates that auto-Abs against myelin components (involved in antibody-mediated demyelination 3 ) and auto-Abs against oligodendrocyte progenitor cell protein, which may interfere with remyelination by eliminating or impeding these cells, 5 seem to play a crucial role in MS immunopathogenesis. In addition to MS-specific mechanisms, there seem to be some common pathways in the development of different autoimmune diseases (AIDs). For example, the level of lymphocyte apoptosis is usually increased for all AIDs.
In addition to carrying out various intranuclear cell functions, histones act as damage-molecules in the extracellular space. 6 Treating animals with exogenous histones leads to systemic inflammation and toxic reactions through activation of Toll-like receptors and inflammasome pathways. The blood-level increase in nucleosome fragments and histones is associated with multiple adverse pathophysiological processes including progression in various AIDs and inflammatory diseases. 6 It has been shown that multifunctional cytokines can influence the human immune system leading to its dysregulation and resulting in the development of different AIDs. 7 In addition, an important and harmful role in the development of MS 8 and other AIDs can be attributed to auto-Abs with catalytic activities (abzymes; ABZs). [9] [10] [11] [12] [13] Artificial abzymes against chemically stable analogues of transition states of different chemical reactions are well described. 9, [14] [15] [16] In the blood of healthy human beings and animals, it is possible to detect auto-Abs against different proteins, peptides, DNA, RNA, oligosaccharides and various other components; their titres vary significantly, but these auto-Abs are usually catalytically inactive. [8] [9] [10] [11] [12] [13] Researchers conducted during the last 30 years have revealed different enzymatic activities for auto-Abs. Auto-Ab elaboration is a specific feature of AID patients. [8] [9] [10] [11] [12] [13] Similar to artificial abzymes, natural ABZs are antibodies against enzyme substrates acting as protein haptens and mimicking transition states of chemical reactions. Antiidiotypic ABZs against catalytic enzyme centres also possess catalytic activities. [8] [9] [10] [11] [12] [13] Abzymes with many different enzymatic activities were revealed as the earliest and most significant markers of onset and development of various AIDs in humans and mammals [8] [9] [10] [11] [12] [13] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] including systemic lupus erythematosus (SLE), [27] [28] [29] MS [22] [23] [24] [25] [26] [30] [31] [32] and EAE 20, 21 in experimental mice. Enzymatic activities of ABZs are actually detectable at the pre-disease stage prior to appearance of obvious AID markers and changes in proteinuria. At that time, antibody titres for various anti-antigens correspond to a range of indices typical for healthy humans and mice. A detectable level of abzymes can indicate the disease onset or pre-disease stage, while an increase in catalytic activities follows the development of clear pathological symptoms. [11] [12] [13] [17] [18] [19] [20] [21] To understand the disease, it is therefore essential to identify all possible parallel and complementary mechanisms of MS development.
Current data demonstrate the appearance of myelin basic protein (MBP)-and DNA-hydrolysing abzymes in the blood of patients with MS, [22] [23] [24] [25] [26] and several other AIDs. [10] [11] [12] [13] IgGs from the CSF of MS patients, which hydrolyse MBP, DNA and polysaccharides, are on average 30-to 60-fold higher than those taken from the sera of the same patients. [30] [31] [32] In AIDs, abzymes hydrolysing MBP can attack the protein of the myelin-proteolipid sheath of axons and can play a harmful role in MS, SLE and other disease pathogenesis. [10] [11] [12] [13] Abzymes with DNase activity are harmful: they are cytotoxic and can penetrate into the nucleus of the cell; they hydrolyse nuclear DNA inducing cell death by apoptosis, which in turn stimulates the development of AIDs. [33] [34] [35] Anti-DNA Abs and ABZs in SLE, MS and other AIDs are usually directed against nucleosomal histone-DNA complexes, which appear during apoptosis and result in internucleosomal cleavage. 36 All autoimmune diseases have initially been suggested to originate from defects in hematopoietic stem cells (HSCs). 37 Later, it was shown that the spontaneous and antigen-induced development of profound experimental autoimmune encephalomyelitis (EAE) 20, 21 and SLE [17] [18] [19] pathologies in autoimmune (AI) prone mice was associated with a specific reorganization of the immune system, including specific changes in the profile of differentiation of bone marrow HSCs in combination with the production of abzymes hydrolysing DNA, ATP, polysaccharides and proteins.
There are several different EAE models, each mimicking a specific facet of MS (for review see 38 ). C57BL/6 mice were recently used to study possible mechanisms of spontaneous, myelin oligodendrocyte glycoprotein (MOG)-and DNA-accelerated development of EAE. 20, 21 We confirmed that immunization with MOG and DNA led to an acceleration of EAE development but was associated with various changes in HSC differentiation profiles, lymphocyte proliferation and apoptosis in different organs of mice. The data showed that DNA and MOG may have to some extent antagonistic effects on these parameters and revealed a noticeable delay of EAE development after immunization with DNA. At the same time, as mentioned above, the main immunogen stimulating the development of various AIDs is not DNA but its complex with histones. 6 Moreover, it is believed that an important role in AID development is played by cytokines. 
| Immunization of mice
C57BL/6 mice were immunized with a gel (150 μL) combining polymeric DNA complex (94 μg), five histones (92 μg) and Pertussis toxin (0.4 μg).
To prepare a conjugate, a solution of 23.6 mg five histones (in 11.8 mL of water) was mixed with 23 mg calf thymus DNA (in 3 mL of water), adding 80 μL of 3 mol/L NaOH (pH 10). After complete dissolution, the mixture was titrated with 1 mol/L hydrochloric acid to pH 7.0 and diluted to 18.8 mL with a physiological solution containing 0.235 mol/L NaCl. As final step a mixture of 18.8 mL of antigen solution, 101. Pertussis toxin, and immunization with DNA without toxin was carried out as described in previously published protocol. 37 The relative weight of mice and proteinuria (relative concentration of total protein in the urine, mg/mL) was analysed as before. [17] [18] [19] [20] [21] Protein concentration in urine was measured using the Bradford assay with a bovine serum albumin standard. For further experiments including the purification of Abs and analysis of their enzymatic activity, 0.5-0.8 mL of blood was collected after decapitation using standard approaches. The relative level of auto-Abs against histones (a mixture of all five histones) was estimated with ELISA test system from EUROIM-MUN (Germany) using purified homogeneous IgGs (0.02 mg/mL for one analysis) and adhering to the manufacturer's instructions, as described previously. 40 The relative concentrations of cytokines (IFNγ, IL-1β and TNFα)
were estimated with ELISA test system from Vector-best (Novosi- 
| IgG purification
Electrophoretically homogeneous mouse IgG preparations were purified using sequential chromatography of plasma proteins on Protein G-Sepharose and following fast protein liquid chromatography (FPLC) gel filtration as described in. [20] [21] [22] [23] [24] [25] [26] [27] [28] To protect Abs from viral and bacterial contamination, they were filtered through syringe-driven filter units (Millex; 0.1 μm) and kept in sterilized tubes. The absence of viral and bacterial colonies in Ab preparations was checked as shown previously. 31, 32 SDS-PAGE analysis proving electrophoretic homogeneity of IgGs under non-reducing conditions (0.1%) was performed in 4-15% gradient gels. Intact IgGs were visualized using silver staining as previously described. [20] [21] [22] [23] [24] [25] [26] [27] [28] To exclude possible artefacts because of canonical enzyme contaminations, IgGs were separated by SDS-PAGE and their proteolytic and DNase activities were detected using a gel assay according to. [20] [21] [22] [23] [24] [25] [26] [27] [28] Activity peaks after electrophoresis were only revealed in the band corresponding to intact IgGs, and there were no other peaks of protein band activities. number of CFU-GM, CFU-E, BFU-E and CFU-GEMM colonies was calculated after 14 days of sample incubation at 37°C and 5% CO 2 in a humidified incubator as described previously.
| DNA-hydrolysing activity assay
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| Analysis of lymphocyte proliferation
Analysis of lymphocyte proliferation in vitro (sum of B and T cells) was carried out as in. [17] [18] [19] [20] [21] Cells ( 
| Apoptosis assay
The analysis of cell apoptosis was performed according to.
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Cells (1 × 10 6 /mL) were incubated in RPMI-1640 medium containing 10 mmol/L HEPES buffer, foetal calf serum (10%), 2 mmol/L Lglutamine, 0.5 mmol/L 2-mercaptoethanol, 100 μg/mL benzylpenicillin and 80 μg/mL gentamicin (5% CO 2 ) at 37°C for 48 hours.
Then, cell samples were washed using 2 mL phosphate-buffered saline supplemented with 0.1% NaN 3 and 0.02% EDTA. 
| Statistical analysis
The results are reported as the mean ± SD of at least three to four independent experiments for each mouse, averaged over seven different mice. Differences between the samples and mouse groups were analysed using Student's t test; P ≤ 0.05 was considered to be statistically significant.
| RESULTS

| Choosing a model for an extended study of the mechanism of EAE development
MOG-induced EAE in mice is frequently used as a model of human MS. 38, 41 The immunization of mice with MOG leads to the development of antibodies against MBP, MOG and DNA, and in addition
initiates the production of abzymes efficiently hydrolysing not only MBP and MOG but also DNA. 20, 21 When immunizing mice with MOG, the significant acceleration of EAE development strongly depends on the use of Pertussis toxin (PT). 41 PT was shown to affect the innate immune response; it can cross the blood-brain-barrier by increasing its permeability. 42 Thus, PT can stimulate the development of EAE in mice immunized with MOG because of increasing the blood-brain barrier permeability for MOG.
Previously we have demonstrated that DNA itself is a weak immunogen, but its immunogenic efficacy dramatically increases in different DNA-protein complexes. 43 Immunization of autoimmune MRL-lpr/lpr mice with a complex of DNA and methylated BSA, without Pertussis toxin, led to a strong acceleration of the development of mouse SLE, associated with the development of antibodies against DNA and against the abzymes efficiently hydrolysing DNA, ATP and oligosaccharides. [17] [18] [19] Comparable to the role of anti-MBP in SLE, high-affinity anti-DNA intrathecal IgGs have been identified
as the major components of the cerebrospinal fluid cells and brains of MS patients. 39 DNase abzymes were revealed in~80%-90% of MS patients. 25, 26 Similar to SLE, 34 DNase abzymes of MS patients 35 are cytotoxic and induce apoptosis; they therefore can play an important role not only in SLE but also in MS pathogenesis. As SLE and MS patients demonstrate some overlap in medical, biochemical, immunological and psychiatric indexes, 44 abzymes with DNase activity to some extent play a similar role in the development of both pathologies. Therefore, analogous to the treatment of MRL-lpr/lpr mice, [17] [18] [19] we first immunized C57BL/6 mice with DNAmet-BSA without toxin. 21 As already shown for the treatment with MOG, the immunization of C57BL/6 mice with DNA without Pertussis toxin leads to the development of EAE (similar to the development of SLE in MRL-lpr/lpr mice), but with a very long delay (approximately 16-20 days after immunization) until the manifestation of typical disease indicators. 21 In the absence of toxin, this delay could be because of a reduced blood-brain barrier permeability for the DNA-met-BSA complex. Anti-DNA Abs in AIDs are usually directed against nucleosomal DNA-histone complexes resulting in cell apoptosis. 36 As these complexes in cooperation with intrinsic human MBP could have an important role in the development of MS, we chose to immunize C57BL/6 mice with a DNA-histone complex combined with Pertussis toxin. In addition to various intranuclear functions, five histones act as damage molecules in the extracellular space. 6 Taking this into account, we analysed the development of Abs targeting histones and abzymes hydrolysing these proteins.
Finally, our study compares the development of EAE over time using four experimental C57BL/6 mice groups (averaging over seven animals for each time-point):
• DNA-histone complex + Pertussis toxin treated C57BL/6 mice,
• untreated control C57BL/6 mice,
• MOG + Pertussis toxin immunized C57BL/6 mice.
• DNA-met-BSA complex (without Pertussis toxin) immunized C57BL/6 mice
| Changes in the weight of mice and proteinuria
Changes in the weight of C57BL/6 mice treated with DNA-histones + Pertussis toxin (further referred to as toxin) were analysed from the day of immunization (at 3 months of age, time-point zero)
for 63 consecutive days. Control experiments with untreated mice and animals treated with MOG + toxin and with DNA-met-BSA were performed in parallel. The data of these experiments are similar to previously published results (comparing the data at 40 days after treatment 20, 21 ) indicating that the conditions were well reproducible.
In contrast to untreated and MOG + toxin-treated mice, but similar to mice treated with DNA-met-BSA complex (decrease in weight compared to control 1.2-fold; R < 0.05), immunization with DNA-histones + toxin also leads to an essential decrease in animal weight (1.1-fold; R < 0.05) during the 63-day observation period (Figure 1A) .
In different animal autoimmune models, the development of pathologies usually correlates with an increase in the concentration of proteins in the urine (proteinuria). [17] [18] [19] [20] [21] Control non-autoimmune CBA and BALB mice do not show proteinuria; at least not during the first 7-10 months (0.1-0.12 mg/mL). [17] [18] [19] [20] [21] Healthy MRL-lpr/lpr mice exhibit low proteinuria (0.38 mg/mL) prior to the development of spontaneous or DNA-induced pronounced SLE. [17] [18] [19] [20] [21] Initial symptom development in MOG-induced C57BL/6 mice is usually observed 5-7 days after their immunization, while the maximum stage of the pathology usually occurs 14-20 days after the treatment. 41, 45 Interestingly, C57BL/6 mice demonstrate significantly higher proteinuria (up to 8-12 mg/mL) at three months of age even before immunization with MOG. 46 While proteinuria increases nearly gradually over time from 7.2 to 27.8 mg/mL in MOG + toxin-treated mice from day 0 to 63, it almost does not change in untreated control mice until day 20 and then gradually increases to 17.0 mg/mL by day 63. After mice are treated with DNA-met-BSA, proteinuria does not markedly change during the first 30 days and then slightly increases to 9.4 mg/mL by day 63. Urine protein levels of mice immunized with DNA-histones + toxin first decrease until day~25, but then increase and become comparable with the levels seen for the DNA-met-BSA complex 30-63 days after immunization ( Figure 1B) .
Thus, the treatment of mice with DNA-histone + toxin and DNA-met-BSA leads to a statistically significant (P < 0.05) decrease in weight and a decrease in proteinuria compared to untreated and MOG + toxin-treated EAE mice (Figure 1 ).
| The relative content of anti-proteins and anti-
DNA Abs
The blood of healthy humans and animals usually contains auto-Abs against DNA and different proteins in low concentration. Figure 1C) . Surprisingly, immunization of F I G U R E 1 Relative changes in parameters characterizing C57BL/6 EAE mice over time. Changes in body weight (A), proteinuria (B), titres of antibodies to DNA (C), MOG (D), histones (E) and cytokines (F) are shown for groups of untreated control mice, and for those treated with MOG + toxin, DNA-met-BSA without toxin, and DNA-histones + toxin. Concentrations of anti-MOG and anti-double-stranded DNA in the sera of C57B2/6 mice were measured using a standard ELISA approach; for details see "Materials and methods" mice with DNA-histones + toxin leads to a significant increase in anti-DNA Abs at 6-14 days, and at 20 days (maximum stage of the pathology), it becomes 5.9-fold higher than at time zero ( Figure 1C ).
In contrast to MOG + toxin-treated mice, the DNA-histones + toxin-treated animals reveal a significant decrease in anti-DNA Ab concentrations at 30-63 days. of the cytokines involved in the acute phase reaction. 48, 49 IL1β is also known as lymphocyte activating factor, which is a momentous mediator of the inflammatory response and is involved in a variety of cellular activities, including cell differentiation, proliferation and apoptosis. 49 Thus, the noticeable increase in the concentrations of TNFα and IL1β in the acute phase of EAE may be influential for the development of autoimmune processes in mice following treatment with DNA-histones + toxin.
| The analysis of the criteria directly associated with antibody activities
IgGs were purified from individual mice by affinity chromatography of plasma proteins on Protein G-Sepharose using special conditions to remove non-specifically bound proteins as described before.
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IgGs were then additionally purified using an FPLC gel filtration. For Previous studies showed that IgGs from control non-autoimmune BALB and CBA mice (at 3-7 months of age) did not possess detectable DNase and protease activities, while IgGs from untreated, MOG + toxin treated and DNA-met-BSA treated EAE mice demonstrated detectable or high activity in hydrolysis of DNA, MOG and MBP. 20, 21 In our study, we confirm these data. Within the usual range of data variability, the estimations and average RAs in this study are very well comparable with those obtained previously. 20, 21 After treatment of C57BL/6 mice with DNA-histones + toxin, IgGs are also active in the hydrolysis of all these substrates.
As demonstrated before, the method of isolation of IgGs developed by us excludes contamination with classical enzymes.
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Based on several very strict criteria developed previously, 
| Time-dependent changes in antibodies catalytic activities
We estimated time-dependent changes in the average RAs of IgGs corresponding to the four experimental groups, with seven animals each ( Figure 3 ). During the course of 63 days, non-treated mice demonstrated on average a nearly linear 6.8-fold increase in DNase activity. After mice were treated with MOG + toxin, we observed a significant 24.4-fold increase in DNase activity at day 20, corresponding to the maximum stage of the pathology, followed by a significant decrease at 40-63 days.
Immunization of mice with DNA-met-BSA without toxin was associated with remarkably lower DNase activity up to day~20, increasing only from~25 to 30 days onwards, and reaching an increase by a factor of 159 until day 63 ( Figure 3A ). Similar to MOG-induced effects, treatment of mice with DNA-histones + toxin revealed the first peak of increased DNase activity at 14-20 days.
Comparable to DNA-met-BSA, the activity began to grow very rapidly starting at 25-30 days and at day 63 it was 202-fold higher than at the onset of the experiment and 8-fold higher than maximal activity after mice immunization with MOG + toxin ( Figure 3A) . Thus, the production of Abs against DNA, MBP and histones as well as abzymes hydrolysing these antigens slowly but surely occurs even during the spontaneous development of EAE. For mice aged 3 months (time zero), the relative proteolytic activities of the Abs in the hydrolysis of five histones differ at most by a factor of two.
Immunization of mice with MOG
Overall, the relative change in IgGs protease activity after the immunization of animals with MOG and DNA-met-BSA is comparable but differs for mice treated with a DNA-histone complex. 
| Hematopoietic progenitor colony formation
In the following, we analysed changes in four types of colonies over time: erythroid burst-forming unit, early erythroid colonies (BFU-E); erythroid burst-forming unit, late erythroid colonies (CFU-E); granulocytic-macrophagic colony-forming unit (CFU-GM);
and granulocytic, erythroid, myeloid colony-forming unit (CFU-GEMM).
In untreated control mice, the average numbers of BFU-E and CFU-E were nearly the same during the first 20-25 days, and increased 2.1-and 4.1-fold, respectively, by day 63 (Figure 5A ,B).
Treating mice with MOG + toxin led to changes in BFU-E and CFU-E colonies going in opposite directions. The number of BFU-E colonies decreased 1.9-fold in the acute phase of EAE (at 6-20 days), and continuously increased until day 63 by a factor of 1.8 compared to time zero of the experiment ( Figure 5A ). There was a very sharp 6.5-fold increase of the relative number of CFU-E colonies at 6-10 days, with a slight~1.1-fold decrease in their number during days 20-63 ( Figure 5B ). In the case of only mice immunized with the DNA-histone + toxin, there was a significant continuous increase in the number of BFU-E colonies, 1.5-fold on average from day 7-63.
The mice immunized with DNA-met-BSA showed an increase in the number of colonies after 25 days and at day 63 the numbers were approximately 1.4-fold higher than that at time zero ( Figure 5A ).
Both antigens (DNA-histone + toxin and DNA-met-BSA without toxin) resulted in very small changes in the number of CFU-E colonies during 0-63 days ( Figure 5B ).
To some extent, a comparable increase in the number of CFU-GM colonies was observed in untreated control mice and animals immunized with DNA-histone + toxin and DNA-met-BSA without toxin ( Figure 5C ). Only for mice immunized with MOG + toxin, a sharp 1.6-fold decrease in the CFU-GM colonies was observed up to day 10, followed by a slow growth in their number until day 63. fold. Treating mice with MOG + toxin and DNA-histone + toxin leads to comparable profiles and levels of changes in lymphocyte proliferation in the spleen, with two well-defined peaks at 14 (2.6-and 2.3-fold, respectively) and 40 days (1.6-and 2.3-fold, respectively).
We cannot exclude that a significant difference in the profiles of spleen lymphocyte proliferation by DNA-met-BSA without toxin and DNA-histone + toxin may occur because of the effect of the toxin on the proliferation. Moreover, we cannot rule out that to some extent a stronger proliferation of lymphocytes after immunization with DNA-histone + toxin is associated with the increased immunogenicity of the DNA complex with histones.
| Cell apoptosis assay
An important role in the development of AIDs associated with the production of autoantibodies and abzymes may arise from apoptosis of cells synthesizing harmful immunoglobulins. [8] [9] [10] [11] [12] [13] During day 0-63 In our experiments, mice treated with DNA-histone + toxin exhibit an increase in the concentration of TNFα, which is involved in systemic inflammation and the acute phase reactions, 48, 49 and IL1β, which is an important mediator of the inflammatory response and activator of lymphocytes 49 in the acute phase of EAE ( Figure 1F ).
Interestingly, immunization of mice with MOG + toxin leads to the production of Abs and abzymes not only for this protein but also targeting DNA, while the treatment of animals with DNA-histone + toxin induces the development of IgGs hydrolysing histones, DNA, MOG and MBP. It is an important finding that these activities are significantly higher after immunization of mice with antigens used together with the toxin (Figure 3) , as the latter increases the penetration of antigens through the blood-brain barrier.
As shown earlier [17] [18] [19] [20] [21] | 5829 phase of EAE (7-20 days after immunization) (Figure 4) , while the initial stage of production of DNase antibodies is observed only after 20-25 days ( Figure 3A ). Interestingly, a strong delay (at 18-20 days)
of the initial stage of production of DNA-hydrolysing antibodies is observed for both antigens containing DNA (DNA-met-BSA and histone-DNA + toxin) ( Figure 3A ). It should be told that in this situation, that is in the earliest stage of human AIDs, there is usually a production of abzymes against only one specific antigen, for example SLE (anti-DNA), MS (anti-MBP) or autoimmune Hashimoto thyroiditis (anti-thyroglobulin). [8] [9] [10] [11] [12] [13] In the later stages of autoimmune patholo- 52 In addition, SLE and MS patients demonstrate some similarity in the development of medical, biochemical and immunological indexes, including a comparable change in the profiles of brain stem cell differentiation and lymphocyte proliferation. [11] [12] [13] 20, 21, 53 The similarity of some immunological indexes between MS and SLE supports the assumption that anti-MBP with proteolytic activity may occur in SLE patients. Interestingly, DNase Abs are on averagẽ 57-fold more active in SLE than MS, while MBP-hydrolysing activity in MS is~7-to 10-fold higher than in SLE patients. 27 Taken together, the development of EAE in mice is associated with changes in the profiles of the differentiation of bone marrow stem cells, changes in the levels of lymphocyte proliferation in various organs, significant levels of cell apoptosis, the production of harmful auto-Abs to DNA, MBP and histones as well as abzymes with various activities and increased concentrations of cytokines.
It is believed that in individual patients with AIDs, the development of initial normal immune reactions can be stimulated by foreign antigens of different bacterial as well as viral infections. [54] [55] [56] [57] Molecular homology and mimicry between human and viral agents such as Epstein-Barr, measles, hepatitis B, herpes simplex, influenza and papilloma viruses may be involved in the autoimmune pathogenesis of MS. 58 Perhaps the antigens of such viruses (and/or some bacteria) are able to penetrate the blood-brain barrier and induce a change in the profile of differentiation and the level of proliferation of bone marrow stem cells in case of long periods of illness and complications. As the abzymes in the bone marrow of MS patients are more active than those in the blood of the same MS patients, [30] [31] [32] we can assume that the bone marrow lymphocytes are subjected by viral antigens to a special type of differentiation, leading them to synthesize harmful autoantibodies and abzymes in the bone marrow and in different organs.
Here we show for the first time that rapid development of EAE in mice can be stimulated not only by their immunization with MOG + toxin, but also with DNA-met-BSA, and DNA-histone + toxin. We cannot exclude that the initial stages of MS development in humans may be associated with an immunization with a variety of antigens.
